The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Promoter Hypermethylation Is Associated With Tumor Location, Stage, and Subsequent Progression in Transitional Cell Carcinoma
Abstract
Purpose: Transitional cell carcinoma (TCC) is a pan-urothelial disease characterized by multiplicity. Although little is known about the molecular events in upper-tract TCC, similar carcinogenic mechanisms are thought to occur throughout the urinary tract. However, we have previously shown that distinct patterns of microsatellite instability occur in upper and lower urinary tract TCC, suggesting biologic differences between these tumors. Here we investigate the extent of promoter hypermethylation in TCC throughout the urinary tract. Patients and Methods: Tissue was obtained from 280 patients (median follow-up, 56 months) whose tumors comprised 116 bladder and 164 upper-tract tumors (UTT). Analysis for hypermethylation at 11 CpG islands, using methylation-sensitive polymerase chain reaction and bisulfite sequencing, was performed for each sample and compared with the tumor's clinicopathologic details, microsatellite instability status, and subsequent behavior. Results: Promoter methylation was present in 86% of TCC and occurred both more frequently and more extensively in UTT (94%) than in bladder tumors (76%; P < .0001). Methylation was associated with advanced tumor stage (P = .0001) and higher tumor progression (P = .03) and mortality rates (P = .04), when compared with tumors without methylation. Multivariate analysis revealed that methylation at the RASSF1A and DAPK loci, in addition to tumor stage and grade, were associated with disease progression (P < .04). Conclusion: Despite morphologic similarities, there are genetic and epigenetic differences between TCC in the upper and lower urinary tracts. Methylation occurs commonly in urinary tract tumors, may affect carcinogenic mechanisms, and is a prognostic marker and a potential therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
CpG island methylator phenotype in colorectal cancer
Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., & Issa, J.-P. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8681 · Cited by 2,523
A gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Extracolonic cancer in hereditary nonpolyposis colorectal cancer
Watson, P., & Lynch, H. T. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3<677::aid-cncr2820710305>3.0.co;2-# · Cited by 738
Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer
Peltomäki, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.060 · Cited by 706
Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck, C., Ohneseit, P. F., Gonzalez‐Zulueta, M., Esrig, D., Miyao, N., Tsai, Y., Lerner, S. P., Schmütte, C., Yang, A. S., & Cote, R. (1994) · PubMed · Cited by 680
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype
Toyota, M., Ohe-Toyota, M., Ahuja, N., & Issa, J.-P. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.710 · Cited by 473
Maruyama, R., Toyooka, S., Toyooka, K. O., Harada, K., Virmani, A. K., Zöchbauer‐Müller, S., Farinas, A. J., Vakar‐Lopez, F., Minna, J. D., Sagalowsky, A. I., et al. (2001) · PubMed · Cited by 422
Hypermethylation of multiple genes in pancreatic adenocarcinoma.
Ueki, T., Toyota, M., Sohn, T. A., Yeo, C. J., Issa, J. J., Hruban, R. H., & Goggins, M. (2000) · PubMed · Cited by 407
Bender, C. M., Pao, M. M., & Jones, P. A. (1998) · PubMed · Cited by 380
van Engeland, M., Weijenberg, M. P., Roemen, G. M. J. M., Brink, M., de Bruïne, A. P., Goldbohm, R. A., van den Brandt, P. A., Baylin, S. B., de Goeij, A. F. P. M., & Herman, J. G. (2003) · PubMed · Cited by 299
Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies
Hafner, C., Knuechel, R., Stoehr, R., & Hartmann, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10544 · Cited by 200
Genetics supersedes epigenetics in colon cancer phenotype
Yamashita, K., Dai, T., Dai, Y., Yamamoto, F., & Perucho, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00190-9 · Cited by 188
Distinct patterns of microsatellite instability are seen in tumours of the urinary tract
Catto, J. W. F., Azzouzi, A.-R., Amira, N., Rehman, I., Feeley, K. M., Cross, S. S., Fromont, G., Sibony, M., Hamdy, F. C., Cussenot, O., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206964 · Cited by 144
Self-citationBeyond the genetic lesions: gene inactivation by promoter hypermethylation in human cancer
Esteller, M., Baylin, S. B., & Herman, J. G. (2000) · Revista de Oncología · doi:10.1007/bf02979467 · Cited by 139
Frequent microsatellite instability in sporadic tumors of the upper urinary tract.
Hartmann, A., Zanardo, L., Edmonston, T. B., Blaszyk, H., Dietmaier, W., Stoehr, R., Cheville, J. C., Junker, K., Wieland, W. F., Knuechel, R., et al. (2002) · PubMed · Cited by 129
Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers
Kuismanen, S. A., Holmberg, M. T., Salovaara, R., Schweizer, P., Aaltonen, L. A., de la Chapelle, A., Nyström, M., & Peltomäki, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12661 · Cited by 125
Ahrendt, S. A., Decker, P. A., Doffek, K. M., Wang, B., Xu, L., Demeure, M. J., Jen, J., & Sidransky, D. (2000) · PubMed · Cited by 93
Catto, J. W. F., Xinarianos, G., Burton, J. L., Meuth, M., & Hamdy, F. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11109 · Cited by 87
Self-citationSlebos, R. J. C., Oh, D. S., Umbach, D. M., & Taylor, J. A. (2002) · PubMed · Cited by 37
Cytogenetic Investigation of Transitional Cell Carcinomas of the Upper Urinary Tract
Cin, P. D., Roskams, T., Poppel, H. V., Balzarini, P., & BERGHE, H. V. D. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00055-2 · Cited by 21
Cited by
Bellmunt, J., von der Maase, H., Mead, G. M., Skoneczna, I., De Santis, M., Daugaard, G., Boehle, A., Chevreau, C., Paz-Ares, L., Laufman, L. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.6979 · Cited by 526
Taby, R., & Issa, J.-P. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20085 · Cited by 407
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Self-citationGenomic Characterization of Upper Tract Urothelial Carcinoma
Sfakianos, J. P., Cha, E. K., Iyer, G., Scott, S. N., Zabor, E. C., Shah, R. H., Ren, Q., Bagrodia, A., Kim, P. H., Hakimi, A. A., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.07.039 · Cited by 284
The Ras-association domain family (RASSF) members and their role in human tumourigenesis
van der Weyden, L., & Adams, D. J. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.06.003 · Cited by 284
Metadata
- Authors
- Catto, J. W. F., Azzouzi, A.-R., Rehman, I., Feeley, K. M., Cross, S. S., Amira, N., Fromont, G., Sibony, M., Cussenot, O., Meuth, M., & Hamdy, F. C.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-05-01
- Volume
- 23
- Issue
- 13
- Pages
- 2903-2910
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2129430629
- Cited by
- 316
- References
- 24
- FWCI
- 7.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.